Status:

COMPLETED

Myocardial Protection With Multiport Antegrade Cold Blood Cardioplegia

Lead Sponsor:

Chaudhry Pervaiz Elahi Institute of Cardiology

Conditions:

Coronary Artery Bypass Surgery

Eligibility:

All Genders

Phase:

PHASE2

Brief Summary

In spite improvements in methods of myocardial protection, peri-operative myocardial damage is still the commonest cause of early morbidity and mortality after technically successful CABG Surgery. Wha...

Detailed Description

A prospective randomized controlled study was conducted between April-2013 and June-2014, in the Department of Cardiac Surgery, Chaudary Pervaiz Elahi Institute of cardiology (CPEIC) Multan, Pakistan....

Eligibility Criteria

Inclusion

  • All patients undergoing isolated conventional CABG were included in the study

Exclusion

  • The redo CABG surgery. Those who required 2 or less than 2 grafts. Patients who had major postoperative neurological complications like stroke. 2nd arterial graft along with LIMA. Patients who need CABG within a week of STEMI or NSTEMI. Patients with calcified or diseased aorta in which single cross clamp technique was used for proximal aorto-coronary anastomosis

Key Trial Info

Start Date :

April 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 1 2014

Estimated Enrollment :

448 Patients enrolled

Trial Details

Trial ID

NCT02303704

Start Date

April 1 2013

End Date

August 1 2014

Last Update

February 9 2021

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Myocardial Protection With Multiport Antegrade Cold Blood Cardioplegia | DecenTrialz